About Dylan Sammut
Articles Written by Dylan Sammut
Healthcare M&A Activity in Third Quarter Leveled Out
Things felt tough in the third quarter. According to the Centers for Disease Control, the United States passed 7 million cases of COVID-19, with over 200,000 confirmed deaths, or 20% of the deaths caused by the pandemic worldwide. The 2020 presidential election kicked... Read More »
Biotech Firms Bet Big on Oncology
The Biotechnology sector is placing a big bet on oncology. Throughout 2020, M&A in the Biotechnology sector has focused heavily on targets involving oncology research and products, both in deal volume and spending. Of the 97 Biotechnology deals reported through... Read More »
Molina Healthcare Acquires Affinity Health Plan
It has been an eventful year for Molina Healthcare (NYSE: MOH). With two acquisitions already on the books for 2020, the company has announced a third. Last week, Molina Healthcare purchased New York-based Affinity Health Plan for $380 million in cash, net of expected... Read More »
Smith & Nephew Returns to the M&A Market
It’s been over a year since Smith & Nephew plc (NYSE: SNN) announced a transaction, but the medical device manufacturer is back on the acquisition trail. On September 29, the company purchased Integra LifeSciences Holdings Corporation’s (NASDAQ: IART)... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
